Global Hair Loss Treatment Products Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Hair Loss Treatment Products Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • FMCG
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Hair Loss Treatment Products Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Hair Loss Treatment Products Market size in 2024 - 2.49 and 2032 - 3.57, highlighting the projected market growth. USD 2.49 Billion USD 3.57 Billion 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 2.49 Billion
Diagram Market Size (Forecast Year)
USD 3.57 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Alès Groupe
  • Gerolymatos International SA
  • iGrow Laser
  • Lexington Intl.LLC.
  • CuralluxLLC.

Global  Hair Loss Treatment Products Market Segmentation, By Product Type (Shampoos and conditioners, Supplements and Vitamins, Serum and Oil, and Others), Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, and Others), Distribution Channel (Hypermarkets and supermarkets, Medical/pharmacy stores, E-commerce, Departmental Stores, Convenience Stores, and Others), Gender (Male, Female, and Children), End User (Hospitals, Home Healthcare Settings, Dermatology Centres, and Others) – Industry Trends and Forecast to 2032

Hair Loss Treatment Products Market

Hair Loss Treatment Products Market Analysis

The hair loss treatment products market is experiencing robust growth driven by rising awareness about hair care and advancements in treatment solutions. Hair loss, a common issue among men and women, has led to increasing demand for effective treatments ranging from topical products to advanced medical therapies. The market encompasses a wide array of products, including shampoos, conditioners, serums, supplements, and medications, targeting specific hair loss conditions such as alopecia areata, traction alopecia, and androgenic alopecia. Technological advancements have played a pivotal role in transforming the market. Innovations such as laser hair regrowth devices, platelet-rich plasma (PRP) therapy, and products containing bioactive compounds such as minoxidil and finasteride have enhanced treatment efficacy. In addition, the development of plant-based and organic formulations has gained traction, appealing to consumers seeking natural solutions. Regions such as North America and Asia-Pacific are emerging as key markets, with factors such as rising disposable incomes, improved access to healthcare, and increasing awareness of advanced hair loss treatments driving growth. As companies continue to invest in research and development, the market is poised for significant expansion, offering tailored solutions to meet diverse consumer needs.

Hair Loss Treatment Products Market Size

The global hair loss treatment products market size was valued at USD 2.49 billion in 2024 and is projected to reach USD 3.57 billion by 2032, with a CAGR of 4.63% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Hair Loss Treatment Products Market Trends

Adoption of Personalized Hair Care Solutions”

The hair loss treatment products market is witnessing a significant trend toward personalized hair care solutions, driven by advancements in technology and growing consumer demand for tailored treatments. Companies are leveraging AI-based diagnostics and genetic testing to develop customized regimens that address individual hair loss conditions, such as androgenic alopecia or alopecia areata. For instance, brands such as HairMax use AI tools to analyze scalp conditions and recommend laser devices or topical solutions specifically suited to the user’s needs. In addition, personalized subscription services offering curated products, including shampoos, serums, and supplements, have gained popularity among younger, tech-savvy consumers. This shift toward personalization enhances treatment efficacy and improves customer satisfaction and loyalty. With rising awareness about the importance of early intervention and tailored care, the market for customized hair loss treatments is expected to grow, offering innovative solutions to meet diverse consumer demands.

Report Scope and Hair Loss Treatment Products Market Segmentation         

Attributes

Hair Loss Treatment Products Key Market Insights

Segments Covered

  • By Product Type: Shampoos and conditioners, Supplements and Vitamins, Serum and Oil, and Others
  • By Disease Type: Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, and Others
  • By Distribution Channel: Hypermarkets and supermarkets, Medical/pharmacy stores, E-commerce, Departmental Stores, Convenience Stores, and Others
  • By End User: Hospitals, Home Healthcare Settings, Dermatology Centres, and Others

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

Ales Grup (Turkey), GEROLYMATOS INTERNATIONAL S.A. (Greece), iGrow Laser (U.S.), Curallux, LLC. (U.S.), Coegin Pharma AB (Sweden), HCell Inc. (U.S.), Freedom Laser Therapy, Inc. (U.S.), Taisho Pharmaceutical Holdings Co., Ltd. (Japan), Thymuskin (Germany), Vitabiotics Ltd. (U.K.), Endo, Inc. (U.S.), Teva Pharmaceuticals USA, Inc. (Israel), Pfizer Inc. (U.S.), Par Pharmaceutical (U.S.), GSK plc (U.K.), Dr. Reddy’s Laboratories Ltd. (India), Abbott (U.S.), Zydus Pharmaceuticals, Inc. (India), Johnson & Johnson Services, Inc. (U.S.), Cipla Inc. (India), and Sun Pharmaceutical Industries Ltd. (India)

Market Opportunities

  • Growing Awareness about Advanced Hair Loss Treatment
  • Increasing Technological Advancements in Hair Loss Treatments

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Hair Loss Treatment Products Market Definition

Hair loss treatment products are specialized formulations and solutions designed to address hair thinning, hair fall, and baldness caused by various factors, such as genetic predisposition, hormonal changes, stress, medical conditions, or environmental influences. These products encompass a wide range of categories, including shampoos, conditioners, serums, supplements, and medications, as well as advanced therapies such as laser devices and platelet-rich plasma (PRP).

Hair Loss Treatment Products Market Dynamics

Drivers

  • Increasing Prevalence of Hair Loss

The increasing prevalence of hair loss has become a significant market driver, with millions of individuals worldwide seeking effective solutions to address this concern. According to the American Academy of Dermatology, approximately 80 million people in the U.S. alone experience hereditary hair loss, with conditions such as androgenic alopecia affecting both men and women. Beyond genetics, factors such as stress, hormonal imbalances, and aging further contribute to hair thinning and baldness. For instance, studies suggest that nearly 40% of women experience noticeable hair loss by age 50, while stress-induced hair fall, or telogen effluvium, has surged in recent years due to lifestyle pressures. This growing prevalence has increased the demand for advanced treatment options, including topical solutions, oral supplements, and laser therapies, prompting manufacturers to develop innovative products to cater to a wider audience and capitalize on this expanding market.

  • Rising Disposable Income

Rising disposable income in developing regions is a key market driver for the hair loss treatment products market, enabling consumers to allocate more resources toward premium and advanced solutions. For instance, data from the World Bank highlights a steady rise in per capita income in countries such as India and China, with India's gross national income per capita reaching $2,388 in 2022, marking significant economic growth. This increased purchasing power has led to a surge in demand for high-quality, specialized hair care products, including serums, supplements, and laser devices. In addition, the growing middle-class population in these regions is becoming more health-conscious and willing to invest in cosmetic and therapeutic solutions for hair loss. For instance, the Indian hair care market, which includes hair loss treatments, is projected to grow at a CAGR of over 6% during the forecast period, reflecting consumers’ shift toward premium and innovative offerings.

Opportunities

  • Growing Awareness about Advanced Hair Loss Treatment

Growing awareness about advanced hair loss treatment options is emerging as a significant market opportunity, encouraging consumers to seek early intervention. With increased access to information through digital platforms and social media, individuals are becoming more informed about available treatments, such as topical solutions such as minoxidil, oral supplements containing biotin, and medical therapies such as platelet-rich plasma (PRP). For instance, platforms such as Instagram and YouTube host countless tutorials and testimonials, making treatments more relatable and accessible to a broader audience. In addition, dermatology clinics and online consultation services have made professional advice easier to obtain, particularly in urban areas. Brands such as Viviscal and Nutrafol have capitalized on this trend by offering personalized solutions backed by clinical research, further gaining consumer trust. This rising awareness promotes early adoption of effective treatments and creates room for innovation and market expansion, particularly in underserved regions.

  • Increasing Technological Advancements in Hair Loss Treatments

Technological advancements in hair loss treatments, such as laser therapies, PRP treatments, and AI-based personalized solutions, have created a market opportunity by significantly improving the effectiveness of these treatments and boosting consumer trust. For instance, laser devices such as the HairMax LaserComb use low-level laser therapy (LLLT) to stimulate hair follicles and promote hair growth, with clinical studies showing its positive effects. Similarly, PRP (platelet-rich plasma) therapy, where a patient's blood is used to stimulate hair regrowth, has gained popularity due to its non-invasive nature and proven results. The introduction of AI-powered platforms such as Nutrafol's personalized hair health plans uses genetic data and lifestyle factors to create customized hair care regimens, enhancing treatment efficacy and user satisfaction. These technological innovations offer a higher level of precision and personalization, attracting consumers who seek more effective and scientifically-backed solutions, thus driving the growth of the hair loss treatment products market.

Restraints/Challenges

  • Side Effects and Safety Concerns

Side effects and safety concerns present a significant challenge in the hair loss treatment products market, as many consumers are hesitant to use products that may cause adverse reactions. For instance, minoxidil, one of the most widely used treatments for hair loss, can cause scalp irritation, dryness, or unwanted facial hair growth in some users. Prescription treatments such as finasteride have been linked to potential side effects such as decreased libido, erectile dysfunction, and mood changes, which can deter consumers from using them, especially given the long-term commitment required for noticeable results. These safety concerns, along with negative publicity from users who experience side effects, can erode consumer confidence in these treatments. As a result, potential users may opt for alternative, less-regulated products or natural remedies, further complicating market growth and acceptance. Manufacturers must ensure that their products are both effective and safe, balancing efficacy with minimal adverse effects to build consumer trust and overcome this market challenge.

  • High Product Costs

High product costs are a significant challenge in the hair loss treatment products market, as many of the effective solutions—ranging from prescription medications such as finasteride and minoxidil to advanced treatments such as laser therapy devices—come with a hefty price tag. For instance, a monthly supply of minoxidil, an FDA-approved topical treatment, can be relatively expensive, while more advanced treatments such as hair growth lasers can cost considerably more, especially for home treatment kits. These ongoing expenses often discourage long-term use, particularly for consumers in price-sensitive markets. In addition, the need for consistent, long-term application of most hair loss products further compounds the financial burden, leading many potential users to abandon treatments before seeing the desired results. The high cost of these products limits accessibility and presents a barrier to widespread market adoption, making affordability a critical challenge for both consumers and manufacturers.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Hair Loss Treatment Products Market Scope

The market is segmented on the basis of product type, disease type, distribution channel, gender, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Shampoos and Conditioners
  • Supplements and Vitamins
  • Serum and Oil
  • Others

Disease Type

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Alopecia Universalis
  • Others

Distribution Channel

  • Hypermarkets and Supermarkets
  • Medical/Pharmacy Stores
  • E-commerce
  • Departmental Stores
  • Convenience Stores
  • Others

Gender

  • Male
  • Female
  • Children

End User

  • Hospitals
  • Home Healthcare Settings
  • Dermatology Centres
  • Others

Hair Loss Treatment Products Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, disease type, distribution channel, gender, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hair loss treatment products market and is expected to maintain this leadership throughout the forecast period, with the U.S. and Canada emerging as key contributors. The region's large and growing population facing hair loss concerns, combined with increasing awareness of available treatments, fuels market demand. In addition, advancements in product offerings and a high adoption rate of both over-the-counter and prescription treatments further support the market's growth. The rising prevalence of hair loss, coupled with a strong focus on cosmetic solutions, ensures that North America remains a critical player in the global market.

Asia-Pacific is projected to experience the highest compound annual growth rate (CAGR) during the forecast period. This growth can be attributed to several key factors, including rising personal disposable income, which allows consumers to invest in hair loss treatment products. The region's rapid globalization has also led to greater exposure to innovative solutions and an increasing preference for premium hair care products. In addition, the aging population in countries such as Japan and China is driving demand, as hair loss becomes more prevalent with age. Increased awareness about hair loss treatment options, fueled by both traditional and digital media, is further contributing to market expansion in this dynamic region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Hair Loss Treatment Products Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Hair Loss Treatment Products Market Leaders Operating in the Market Are:

  • Ales Grup (Turkey)
  • GEROLYMATOS INTERNATIONAL S.A. (Greece)
  • iGrow Laser (U.S.)
  • Curallux, LLC. (U.S.)
  • Coegin Pharma AB (Sweden)
  • HCell Inc. (U.S.)
  • Freedom Laser Therapy, Inc. (U.S.)
  • Taisho Pharmaceutical Holdings Co., Ltd. (Japan)
  • Thymuskin (Germany)
  • Vitabiotics Ltd. (U.K.)
  • Endo, Inc. (U.S.)
  • Teva Pharmaceuticals USA, Inc. (Israel)
  • Pfizer Inc. (U.S.)
  • Par Pharmaceutical (U.S.)
  • GSK plc (U.K.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Abbott (U.S.)
  • Zydus Pharmaceuticals, Inc. (India)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Cipla Inc. (India)
  • Sun Pharmaceutical Industries Ltd. (India)

Latest Developments in Hair Loss Treatment Products Market

  • In September 2023, Alma Lasers partnered with Kate Hudson for the 'Beyond The Trend' Campaign, aiming to showcase its top products, including LMNT, PrimeX, and others
  • In March 2023, Viviscal launched a new line of topical hair care products targeted at women's specific hair concerns. The collection included Viviscal Thickening Shampoo, Viviscal Strengthening Conditioner, and Viviscal Thickening Serum
  • In October 2022, Dr. Groot, a South Korean hair care brand, introduced a shampoo containing brewer's yeast, claiming to benefit the scalp microbiome and reduce hair loss symptoms
  • In August 2022, UNITE Hair debuted the BOOSTA PLUS+ Hair serum, formulated to stimulate hair growth and prevent hair loss by activating stem cells and rejuvenating hair follicles
  • In August 2021, Adon Hair Care Clinic launched the Grow-Dense Hair Serum in the Indian market, an innovative product designed for both men and women to address hair loss and promote regrowth


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1. INTRODUCTION

 

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

 

2. MARKET SEGMENTATION

 

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE

 

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 MARKET GUIDE

2.2.4 COMPANY POSITIONING GRID

2.2.5 COMPANY MARKET SHARE ANALYSIS

2.2.6 MULTIVARIATE MODELLING

2.2.7 TOP TO BOTTOM ANALYSIS 

2.2.8 STANDARDS OF MEASUREMENT

2.2.9 VENDOR SHARE ANALYSIS

2.2.10 SALES VOLUME

2.2.11 EPIDEMIOLOGY MODELLING

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

 

2.3 GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

 

3. MARKET OVERVIEW

 

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

 

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

 

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

 

6. INDUSTRY INSIGHTS

 

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

 

7. INTELLECTUAL PROPERTY (IP) PORTFOLIO

 

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

 

8. COST ANALYSIS BREAKDOWN

 

9. TECHNONLOGY ROADMAP

 

10. INNOVATION TRACKER AND STRATEGIC ANALYSIS

 

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

 

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

 

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

11. REGULATORY COMPLIANCE

 

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

 

11.2.1 CLASS I

11.2.2 CLASS II

11.2.3 CLASS III

 

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

 

12. REIMBURSEMENT FRAMEWORK

 

13. OPPUTUNITY MAP ANALYSIS

 

14. VALUE CHAIN ANALYSIS

 

15. HEALTHCARE ECONOMY

 

15.1 HEALTHCARE EXPENDITURE

15.2 CAPITAL EXPENDITURE

15.3 CAPEX TRENDS

15.4 CAPEX ALLOCATION

15.5 FUNDING SOURCES

15.6 INDUSTRY BENCHMARKS

15.7 GDP RATION IN OVERALL GDP

15.8 HEALTHCARE SYSTEM STRUCTURE

15.9 GOVERNMENT POLICIES

15.10 ECONOMIC DEVELOPMENT

 

16. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRODUCT TYPE

 

16.1 OVERVIEW

16.2 ORAL SUPPLEMENTS

 

16.2.1 PURE BIOTIN SUPPLEMENTS

 

16.2.1.1. HIGH-POTENCY BIOTIN SUPPLEMENTS

16.2.1.2. TIME-RELEASE BIOTIN SUPPLEMENTS

16.2.1.3. VEGAN AND ORGANIC BIOTIN SUPPLEMENTS

16.2.1.4. LIQUID BIOTIN FORMULATIONS

16.2.1.5. OTHERS

 

16.2.2 MULTIVITAMIN COMPLEXES CONTAINING BIOTIN

16.2.3 BIOTIN-ENRICHED HAIR CARE PRODUCTS

 

16.2.3.1. SHAMPOOS

16.2.3.2. CONDITIONERS

16.2.3.3. HAIR OILS 

16.2.3.4. SERUMS

16.2.3.5. OTHERS

 

16.2.4 GUMMIES AND CHEWABLES WITH BIOTIN

16.2.5 BIOTIN-INFUSED FUNCTIONAL BEVERAGES

16.2.6 AMINO ACID COMPLEXES

16.2.7 OMEGA-3 FATTY ACID CAPSULES

16.2.8 COLLAGEN POWDERS

16.2.9 HERBAL SUPPLEMENTS

16.2.10 OTHERS

 

16.3 TOPICAL TREATMENTS

 

16.3.1 HAIR LOSS SHAMPOOS

16.3.2 CONDITIONERS WITH KERATIN AND BIOTIN

16.3.3 SERUMS (MINOXIDIL, BIOTIN-ENRICHED)

16.3.4 HAIR OILS (ARGAN OIL, CASTOR OIL, ONION OIL)

16.3.5 SCALP MASKS AND SCRUBS

 

16.4 PHARMACEUTICAL SOLUTIONS

 

16.4.1 MINOXIDIL (ROGAINE)

16.4.2 FINASTERIDE (PROPECIA)

16.4.3 DUTASTERIDE

16.4.4 ANTI-DHT TOPICAL FORMULATIONS

16.5 OTHERS

 

17. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRODUCT FORM

 

17.1 OVERVIEW

17.2 TABLETS

17.3 CAPSULES

17.4 GUMMIES

17.5 POWDERS

17.6 LIQUID DROPS 

17.7 SPRAYS

17.8 OTHER 

18. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY APPLICATION TYPE

 

18.1 OVERVIEW

18.2 ALOPECIA AREATA

18.3 MALE PATTERN BALDNESS

18.4 FEMALE PATTERN HAIR LOSS

18.5 POSTPARTUM HAIR LOSS

18.6 HAIR THINNING DUE TO STRESS 

18.7 OTHERS

 

19. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRICE RANGE

 

19.1 OVERVIEW

19.2 ENTRY-LEVEL (MASS MARKET)

19.3 MID-RANGE PRODUCTS

19.4 PREMIUM PRODUCTS

 

20. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY DISTRIBUTION CHANNEL

 

20.1 OVERVIEW

20.2 DIRECT TENDER

 

20.3 RETAILS

 

20.3.1 ONLINE 

20.3.2 OFFLINE

 

21. GLOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION

 

21.1 GLOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

 

21.1.1 NORTH AMERICA

 

21.1.1.1. U.S.

21.1.1.2. CANADA

21.1.1.3. MEXICO

 

21.1.2 EUROPE 

 

21.1.2.1. GERMANY

21.1.2.2. FRANCE

21.1.2.3. U.K.

21.1.2.4. HUNGARY

21.1.2.5. LITHUANIA

21.1.2.6. AUSTRIA

21.1.2.7. IRELAND

21.1.2.8. NORWAY

21.1.2.9. POLAND

21.1.2.10. ITALY

21.1.2.11. SPAIN

21.1.2.12. RUSSIA

21.1.2.13. TURKEY

21.1.2.14. NETHERLANDS

21.1.2.15. SWITZERLAND

21.1.2.16. REST OF EUROPE

 

21.1.3 ASIA-PACIFIC

 

21.1.3.1. JAPAN

21.1.3.2. CHINA

21.1.3.3. SOUTH KOREA

21.1.3.4. INDIA

21.1.3.5. AUSTRALIA

21.1.3.6. SINGAPORE

21.1.3.7. THAILAND

21.1.3.8. MALAYSIA

21.1.3.9. INDONESIA

21.1.3.10. PHILIPPINES

21.1.3.11. VIETNAM

21.1.3.12. REST OF ASIA-PACIFIC

 

21.1.4 SOUTH AMERICA

 

21.1.4.1. BRAZIL

21.1.4.2. ARGENTINA

21.1.4.3. PERU

21.1.4.4. REST OF SOUTH AMERICA

 

21.1.5 MIDDLE EAST AND AFRICA

 

21.1.5.1. SOUTH AFRICA

21.1.5.2. SAUDI ARABIA

21.1.5.3. UAE

21.1.5.4. EGYPT

21.1.5.5. KUWAIT

21.1.5.6. ISRAEL

21.1.5.7. REST OF MIDDLE EAST AND AFRICA

 

21.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

 

22. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, SWOT AND DBMR ANALYSIS

 

23. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, COMPANY LANDSCAPE

 

23.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

23.2 MERGERS & ACQUISITIONS

23.3 NEW PRODUCT DEVELOPMENT & APPROVALS

23.4 EXPANSIONS

23.5 REGULATORY CHANGES

23.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

 

24. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, COMPANY PROFILE

 

24.1 CIPLA

 

24.1.1 COMPANY OVERVIEW

24.1.2 REVENUE ANALYSIS

24.1.3 GEOGRAPHIC PRESENCE

24.1.4 PRODUCT PORTFOLIO

24.1.5 RECENT DEVELOPEMENTS

 

24.2 VIVISCAL

 

24.2.1 COMPANY OVERVIEW

24.2.2 REVENUE ANALYSIS

24.2.3 GEOGRAPHIC PRESENCE

24.2.4 PRODUCT PORTFOLIO

24.2.5 RECENT DEVELOPEMENTS

 

24.3 PFIZER INC.

 

24.3.1 COMPANY OVERVIEW

24.3.2 REVENUE ANALYSIS

24.3.3 GEOGRAPHIC PRESENCE

24.3.4 PRODUCT PORTFOLIO

24.3.5 RECENT DEVELOPEMENTS

 

24.4 DR. REDDY’S LABORATORIES LTD.

 

24.4.1 COMPANY OVERVIEW

24.4.2 REVENUE ANALYSIS

24.4.3 GEOGRAPHIC PRESENCE

24.4.4 PRODUCT PORTFOLIO

24.4.5 RECENT DEVELOPEMENTS

 

24.5 REGAINE

 

24.5.1 COMPANY OVERVIEW

24.5.2 REVENUE ANALYSIS

24.5.3 GEOGRAPHIC PRESENCE

24.5.4 PRODUCT PORTFOLIO

24.5.5 RECENT DEVELOPEMENTS

24.6 CONCERT PHARMACEUTICALS

 

24.6.1 COMPANY OVERVIEW

 

24.6.2 REVENUE ANALYSIS

24.6.3 GEOGRAPHIC PRESENCE

24.6.4 PRODUCT PORTFOLIO

24.6.5 RECENT DEVELOPEMENTS 

 

24.7 MERCK & CO., INC

 

24.7.1 COMPANY OVERVIEW

24.7.2 REVENUE ANALYSIS

24.7.3 GEOGRAPHIC PRESENCE

24.7.4 PRODUCT PORTFOLIO

24.7.5 RECENT DEVELOPEMENTS 

 

24.8 SUN PHARMACEUTICAL INDUSTRIES LTD.

 

24.8.1 COMPANY OVERVIEW

24.8.2 REVENUE ANALYSIS

24.8.3 GEOGRAPHIC PRESENCE

24.8.4 PRODUCT PORTFOLIO

24.8.5 RECENT DEVELOPEMENTS 

 

24.9 ABBOTT

 

24.9.1 COMPANY OVERVIEW

24.9.2 REVENUE ANALYSIS

24.9.3 GEOGRAPHIC PRESENCE

24.9.4 PRODUCT PORTFOLIO

24.9.5 RECENT DEVELOPEMENTS

 

24.10 ALES GROUP SINGAPORE PTE. LTD

 

24.10.1 COMPANY OVERVIEW

24.10.2 REVENUE ANALYSIS

24.10.3 GEOGRAPHIC PRESENCE

24.10.4 PRODUCT PORTFOLIO

24.10.5 RECENT DEVELOPEMENTS

 

24.11 COSTCO WHOLESALE CORPORATION (KIRKLAND SUGNATURE)

 

24.11.1 COMPANY OVERVIEW

24.11.2 REVENUE ANALYSIS

24.11.3 GEOGRAPHIC PRESENCE

24.11.4 PRODUCT PORTFOLIO

24.11.5 RECENT DEVELOPEMENTS

 

24.12 JOHNSON & JOHNSON CONSUMER INC.

 

24.12.1 COMPANY OVERVIEW

24.12.2 REVENUE ANALYSIS

24.12.3 GEOGRAPHIC PRESENCE

24.12.4 PRODUCT PORTFOLIO

24.12.5 RECENT DEVELOPEMENTS

 

24.13 VITABIOTICS LTD.

 

24.13.1 COMPANY OVERVIEW

24.13.2 REVENUE ANALYSIS

24.13.3 GEOGRAPHIC PRESENCE

24.13.4 PRODUCT PORTFOLIO

24.13.5 RECENT DEVELOPEMENTS

 

24.14 NANOGEN

 

24.14.1 COMPANY OVERVIEW

24.14.2 REVENUE ANALYSIS

24.14.3 GEOGRAPHIC PRESENCE

24.14.4 PRODUCT PORTFOLIO

24.14.5 RECENT DEVELOPEMENTS

 

24.15 DR. KURT WOLFF GMBH & CO. KG

 

24.15.1 COMPANY OVERVIEW

24.15.2 REVENUE ANALYSIS

24.15.3 GEOGRAPHIC PRESENCE

24.15.4 PRODUCT PORTFOLIO

24.15.5 RECENT DEVELOPEMENTS

 

24.16 HISTOGEN INC

 

24.16.1 COMPANY OVERVIEW

24.16.2 REVENUE ANALYSIS

24.16.3 GEOGRAPHIC PRESENCE

24.16.4 PRODUCT PORTFOLIO

24.16.5 RECENT DEVELOPEMENTS

 

24.17 ACLARIS THERAPEUTICS, INC.

 

24.17.1 COMPANY OVERVIEW

24.17.2 REVENUE ANALYSIS

24.17.3 GEOGRAPHIC PRESENCE

24.17.4 PRODUCT PORTFOLIO

24.17.5 RECENT DEVELOPEMENTS

 

24.18 HCELL INC.

 

24.18.1 COMPANY OVERVIEW

24.18.2 REVENUE ANALYSIS

24.18.3 GEOGRAPHIC PRESENCE

24.18.4 PRODUCT PORTFOLIO

24.18.5 RECENT DEVELOPEMENTS

24.19 GLAXOSMITHKLINE

 

24.19.1 COMPANY OVERVIEW

24.19.2 REVENUE ANALYSIS

24.19.3 GEOGRAPHIC PRESENCE

24.19.4 PRODUCT PORTFOLIO

24.19.5 RECENT DEVELOPMENTS

 

24.20 PERRIGO COMPANY PLC 

 

24.20.1 COMPANY OVERVIEW

24.20.2 REVENUE ANALYSIS

24.20.3 GEOGRAPHIC PRESENCE

24.20.4 PRODUCT PORTFOLIO

24.20.5 RECENT DEVELOPEMENTS

 

24.21 ALLERGAN

 

24.21.1 COMPANY OVERVIEW

24.21.2 REVENUE ANALYSIS

24.21.3 GEOGRAPHIC PRESENCE

24.21.4 PRODUCT PORTFOLIO

24.21.5 RECENT DEVELOPMENTS

 

24.22 CASSIOPEA, INC.

 

24.22.1 COMPANY OVERVIEW

24.22.2 REVENUE ANALYSIS

24.22.3 GEOGRAPHIC PRESENCE

24.22.4 PRODUCT PORTFOLIO

24.22.5 RECENT DEVELOPEMENTS

 

24.23 HISTOGEN INC.

 

24.23.1 COMPANY OVERVIEW

24.23.2 REVENUE ANALYSIS

24.23.3 GEOGRAPHIC PRESENCE

24.23.4 PRODUCT PORTFOLIO

24.23.5 RECENT DEVELOPEMENTS

 

24.24 FOLLICUM AB

 

24.24.1 COMPANY OVERVIEW

24.24.2 REVENUE ANALYSIS

24.24.3 GEOGRAPHIC PRESENCE

24.24.4 PRODUCT PORTFOLIO

24.24.5 RECENT DEVELOPEMENTS

 

24.25 LEXINGTON INTL., LLC.

 

24.25.1 COMPANY OVERVIEW

24.25.2 REVENUE ANALYSIS

24.25.3 GEOGRAPHIC PRESENCE

24.25.4 PRODUCT PORTFOLIO

24.25.5 RECENT DEVELOPMENTS

 

24.26 PURETECH

 

24.26.1 COMPANY OVERVIEW

24.26.2 REVENUE ANALYSIS

24.26.3 GEOGRAPHIC PRESENCE

24.26.4 PRODUCT PORTFOLIO

24.26.5 RECENT DEVELOPEMENTS

 

24.27 AMOREPACIFIC CORPORATION

 

24.27.1 COMPANY OVERVIEW

24.27.2 REVENUE ANALYSIS

24.27.3 GEOGRAPHIC PRESENCE

24.27.4 PRODUCT PORTFOLIO

24.27.5 RECENT DEVELOPMENTS

 

24.28 LG HOUSEHOLD & HEALTH CARE

 

24.28.1 COMPANY OVERVIEW

24.28.2 REVENUE ANALYSIS

24.28.3 GEOGRAPHIC PRESENCE

24.28.4 PRODUCT PORTFOLIO

24.28.5 RECENT DEVELOPMENTS

 

24.29 KERASYS 

 

24.29.1 COMPANY OVERVIEW

24.29.2 REVENUE ANALYSIS

24.29.3 GEOGRAPHIC PRESENCE

24.29.4 PRODUCT PORTFOLIO

24.29.5 RECENT DEVELOPMENTS

 

24.30 MEDIHEAL

 

24.30.1 COMPANY OVERVIEW

24.30.2 REVENUE ANALYSIS

24.30.3 GEOGRAPHIC PRESENCE

24.30.4 PRODUCT PORTFOLIO

24.30.5 RECENT DEVELOPMENTS

24.31 TONYMOLY

 

24.31.1 COMPANY OVERVIEW

24.31.2 REVENUE ANALYSIS

24.31.3 GEOGRAPHIC PRESENCE

24.31.4 PRODUCT PORTFOLIO

24.31.5 RECENT DEVELOPMENTS

 

24.32 HANBANG 

 

24.32.1 COMPANY OVERVIEW

24.32.2 REVENUE ANALYSIS

24.32.3 GEOGRAPHIC PRESENCE

24.32.4 PRODUCT PORTFOLIO

24.32.5 RECENT DEVELOPMENTS

 

24.33 ELISHACOY

 

24.33.1 COMPANY OVERVIEW

24.33.2 REVENUE ANALYSIS

24.33.3 GEOGRAPHIC PRESENCE

24.33.4 PRODUCT PORTFOLIO

24.33.5 RECENT DEVELOPMENTS

 

24.34 NATURE REPUBLIC

 

24.34.1 COMPANY OVERVIEW

24.34.2 REVENUE ANALYSIS

24.34.3 GEOGRAPHIC PRESENCE

24.34.4 PRODUCT PORTFOLIO

24.34.5 RECENT DEVELOPMENTS

 

24.35 ARIUL

 

24.35.1 COMPANY OVERVIEW

24.35.2 REVENUE ANALYSIS

24.35.3 GEOGRAPHIC PRESENCE

24.35.4 PRODUCT PORTFOLIO

24.35.5 RECENT DEVELOPMENTS

 

24.36 AESTHETIC HOUSE

 

24.36.1 COMPANY OVERVIEW

24.36.2 REVENUE ANALYSIS

24.36.3 GEOGRAPHIC PRESENCE

24.36.4 PRODUCT PORTFOLIO

24.36.5 RECENT DEVELOPMENTS

24.37 DR. FOR HAIR (GLOBALN BIOTECH INC.)

 

24.37.1 COMPANY OVERVIEW

24.37.2 REVENUE ANALYSIS

24.37.3 GEOGRAPHIC PRESENCE

24.37.4 PRODUCT PORTFOLIO

24.37.5 RECENT DEVELOPMENTS

 

24.38 INNOHERB

 

24.38.1 COMPANY OVERVIEW

24.38.2 REVENUE ANALYSIS

24.38.3 GEOGRAPHIC PRESENCE

24.38.4 PRODUCT PORTFOLIO

24.38.5 RECENT DEVELOPMENTS

 

24.39 LANEIGE

 

24.39.1 COMPANY OVERVIEW

24.39.2 REVENUE ANALYSIS

24.39.3 GEOGRAPHIC PRESENCE

24.39.4 PRODUCT PORTFOLIO

24.39.5 RECENT DEVELOPMENTS

 

24.40 HERA

 

24.40.1 COMPANY OVERVIEW

24.40.2 REVENUE ANALYSIS

24.40.3 GEOGRAPHIC PRESENCE

24.40.4 PRODUCT PORTFOLIO

24.40.5 RECENT DEVELOPMENTS

 

24.41 COSRX

 

24.41.1 COMPANY OVERVIEW

24.41.2 REVENUE ANALYSIS

24.41.3 GEOGRAPHIC PRESENCE

24.41.4 PRODUCT PORTFOLIO

24.41.5 RECENT DEVELOPMENTS

 

24.42 MISSHA

 

24.42.1 COMPANY OVERVIEW

24.42.2 REVENUE ANALYSIS

24.42.3 GEOGRAPHIC PRESENCE

24.42.4 PRODUCT PORTFOLIO

24.42.5 RECENT DEVELOPMENTS

 

24.43 SIMPLYO

 

24.43.1 COMPANY OVERVIEW

24.43.2 REVENUE ANALYSIS

24.43.3 GEOGRAPHIC PRESENCE

24.43.4 PRODUCT PORTFOLIO

24.43.5 RECENT DEVELOPMENTS

 

24.44 SHISEIDO PROFESSIONAL

 

24.44.1 COMPANY OVERVIEW

24.44.2 REVENUE ANALYSIS

24.44.3 GEOGRAPHIC PRESENCE

24.44.4 PRODUCT PORTFOLIO

24.44.5 RECENT DEVELOPMENTS

 

24.45 BIODERMA

 

24.45.1 COMPANY OVERVIEW

24.45.2 REVENUE ANALYSIS

24.45.3 GEOGRAPHIC PRESENCE

24.45.4 PRODUCT PORTFOLIO

24.45.5 RECENT DEVELOPMENTS

 

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

 

25. RELATED REPORTS

 

26. QUESTIONNAIRE

 

27. CONCLUSION

 

28. ABOUT DATA BRIDGE MARKET RESEARCH

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global  Hair Loss Treatment Products Market Segmentation, By Product Type (Shampoos and conditioners, Supplements and Vitamins, Serum and Oil, and Others), Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, and Others), Distribution Channel (Hypermarkets and supermarkets, Medical/pharmacy stores, E-commerce, Departmental Stores, Convenience Stores, and Others), Gender (Male, Female, and Children), End User (Hospitals, Home Healthcare Settings, Dermatology Centres, and Others) – Industry Trends and Forecast to 2032 .
The Global Hair Loss Treatment Products Market size was valued at USD 2.49 USD Billion in 2024.
The Global Hair Loss Treatment Products Market is projected to grow at a CAGR of 4.63% during the forecast period of 2025 to 2032.
The major players operating in the market include Alès Groupe, Gerolymatos International SA, iGrow Laser, Lexington Intl.LLC., CuralluxLLC., Follicum AB, HCell Inc., Freedom Laser TherapyInc., Taisho Pharmaceutical Holdings Co.Ltd., Vita-Cos-Med Klett-Loch GmbH, Vitabiotics Ltd., WOCKHARDT, Teva Pharmaceuticals USAInc., Pfizer Inc., Par Pharmaceutical, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., Abbott, Zydus PharmaceuticalsInc., Johnson & Johnson ServicesInc., Cipla Inc. and Sun Pharmaceutical Industries Ltd. .
The market report covers data from U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Industry Related Reports

Testimonial